Cardiovascular disease in diabetes mellitus

Medicina Clinica

Volumn 118, Issue 8, 2002, Pages 306-311

  Ampudia Blasco, Francisco Javier ^a   Navarro, Jorge ^b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; DIABETES MELLITUS; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MORTALITY; REVIEW; ARTICLE; CAUSE OF DEATH; CLINICAL FEATURE; DISEASE ASSOCIATION; DYSLIPIDEMIA; HEART DISEASE; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RISK FACTOR; SEX RATIO;

CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA;

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN;

EID: 0037045821     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(02)72367-1     Document Type: Article

References (64)

1. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS38
2. Diabetes mellitus and cardiovascular disease in women
3. Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels: The Paris Prospective Study, ten years later
4. Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres: The World Health Organization Multinational Study of vascular disease in diabetics
5. Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women
6. Diabetes and atherosclerosis: An epidemiologic view
7. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
8. Coronary heart disease and risk factors in NIDDM-experience from the United Kingdom Prospective Diabetes Study
9. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study
10. Determinants of hospital admissions and case fatality in diabetic patients with myocardial infarction
11. Prevalence and mortality of acute myocardial infarction in patients with diabetes
12. Heart abnormalities in IDDM
13. Diabetic myocardial infartion. Interaction of diabetes with other risk factors
14. Prognosis of acute myocardial infarction in diabetic and non-diabetic patients
15. Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: Assessment by exercise thallium scintigraphy
16. Resting electrocardiographic abnormalities suggestive of asymptomatic ischaemic heart disease associated with non-insulin dependent diabetes mellitus in a defined population
17. Clinical features of unrecognised myocardial infarction - Silent and symptomatic. Eighteen year follow-up: The Framingham study
18. Exercise-induced silent ischemia: Age, diabetes mellitus, previous myocardial infarction and prognosis
19. Significance of silent myocardial ischemia during exercise testing in patients with diabetes mellitus: A report from coronary artery surgery study (CASS) registry
20. Prevalence of silent myocardial ischemia detected by 24-hour ambulatory electrocardiography, and its association with new coronary events at 40-month follow-up in elderly diabetic and non-diabetic patients with coronary artery disease
21. Silent ischemia during daily life is an independent predictor of mortality in stable angina
22. Silente coronary artery disease in diabetes- a feature of autonomic neuropathy or accelerated atherosclerosis?
23. Clinical course of myocardial infarction among diabetic patients
24. Myocardial infarct site and mortality in diabetes
25. Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analysis of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, Phase II
26. Outcome of patients with diabetes mellitus and myocardial infarction treated with thrombolytic agents
27. The Bedford Survey: Ten year mortality rates in newly diagnosed controls and risk indices for coronary heart disease in borderline diabetics
28. Hyperglycemia and cardiovascular disease in type 2 diabetes
29. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95, 783 individuals followed for 12.4 years
30. Diabetes and cardiovascular disease: The Framingham study
31. Differences in cardiovascular morbidity and mortality between previously known and newly diagnosed adult diabetics
32. Mortality and morbidity during a five-year follow-up of diabetics with myocardial infarction
33. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: Contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis
34. Left ventricular regional function after acute myocardial infarction in diabetic patients
35. The extent of coronary artery disease in diabetic patients with myocardial infarction: An ECG study
36. Evidence for a specific heart disease of diabetes in humans
37. Microvascular heart disease in diabetes mellitus
38. Capillary microaneurysms in the human diabetic heart
39. Human coronary microvessels in diabetics and ischaemia. Morphometric study of autopsy material
40. Cardiac function and coronary arteriography in asymptomatic type 1 (insulin-dependent) diabetic patients: Evidence for a specific diabetic heart disease
41. Diabetic cardiomyopathy: A unique entity or a complication of coronary artery disease?
42. Prevalence and significance of left ventricular filling abnormalities determined by Doppler echocardiography in young type 1 (insulin dependent) diabetic patients
43. Impairment of diastolic function in middle-aged type 1 (insulin dependent) and type 2 (non insulin dependent) diabetic patients free of cardiovascular disease
44. Microangiopathy as a prognostic indicator in diabetic patients suffering from acute myocardial infarction
45. Blood viscosity, fibrinogen and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study
46. Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction
47. Cardiovascular autonomic neuropathy: Clinical manifestations and measurement
48. Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients
49. Prolonged QT period in diabetic autonomic neuropathy: A possible role in sudden death?
50. Radionuclide analysis of left ventricular diastolic filling in diabetes mellitus with and without cardiac autonomic neuropathy
51. Cholesterol lowering with simvastatin improvos prognosis of diabetic patients with coronary heart disease
52. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
53. Collaborative overview of randomised trials of antiplatelet therapy I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
54. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes
55. Increased prevalence of significant coronary artery calcification in patients with diabetes
56. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Colloborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
57. Enzymatic evidence of impaired reperfusion in diabetic subjects after thrombolytic therapy for acute myocardial infarction- a role for plasminogen activator inhibitor?
58. Effects of metaprolol on mortality and late infarction in diabetics with suspected acute myocardial infarction: Retrospective data from two large studies
59. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the survival and left ventricular enlargement trial
60. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year
61. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus
62. Survival af 15-18 years after coronary bypass grafting for angina in women
63. Clinical and angiographic outcomes after coronary artery stenting for acute of threatened closure after percutaneous coronary angioplasty: Initial results with a ballon-expandable, stainless steel design
64. Comparison of coronary bypass surgery with angioplasty in patients with mutivessel disease